chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccine on 2/8 at 2:50pm. On 2/9 at 10am, patient was found unresponsive. EMS noted R gaze preference and L sided contracture. Patient was intubated and symptoms resolved when given Versed. Concern for seizure activity.
swelling around injection site; redness around injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE SWELLING and INJECTION SITE ERYTHEMA (redness around injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING and INJECTION SITE ERYTHEMA (redness around injection site). At the time of the report, INJECTION SITE SWELLING and INJECTION SITE ERYTHEMA (redness around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Concomitant product use was not provided by the reporter. No treatment information was provided.
About 1 week in a half later after the vaccine I felt very tired and felt like I couldn't breath. I went to the Emergency room they did lab work & a CT scan and that's when they seen I had a blood cloth in my lungs. I got admitted I was hospitalized for 2 days and they also gave me oxygen to take home when I was released. I am currently still on oxygen and I still feel very tired I can't do  a lot of things because I get tired right away. I also have back pain and I have to continue paying for my medication something that was not in my budget.
Started menstrual cycle 9 days after vaccine - a 19 day cycle when I normally have an average 40 day cycle; included extremely heavy bleeding instead of my normal light to medium. Also have had severe headaches daily since 4/25.
Two nights after receiving vaccine patient was unable to sleep for two nights. Then the following week, about 10 days after the vaccine he went to using a walker and then a wheelchair and now has no use of his legs, his core strength is very limited, and one arm is affected. He also cannot sit unassisted.
Skin lesion on scrotum, edema, erythema, and tenderness of right inguinal area and right side of scrotum. Could be consistent with auto innoculation of vaccina vs genital herpes.
Client was mistakenly vaccinated with a vial of vaccine that had expired the day before. Medical director and manufacturer were contacted, and the recommendation is to revaccinate the client. Client was called and made aware of the issue, and he will call us back to make an appointment for his next dose.
Pt.'s mother calling to report approx. 2 1/2" red, swollen, warm area to injection site ( (L) arm). Pt c/o itching and burning at site. C/O headache and low grade fever.  Pt developed red, flat, lesion,  with whitish center, approx. 1" in diameter, to (L) outer breast region  the next day. Headache ongoing along with low grade of 100.1.
SEVERE CHEST PAIN; ACHES EVERY WHERE; FEVER; SO WEAK COULD HARDLY CRAWL OUT OF BED FOR 5 DAYS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced severe chest pain, aches every where, fever, and so weak could hardly crawl out of bed for 5 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe chest pain, aches every where, fever and so weak could hardly crawl out of bed for 5 days was not reported. This report was non-serious.
The pt experienced puffy upper eyelids which developed 1/2 hour post vax.
Pt said that his left arm started swelling up and getting warm with pain in the late evening. He did not take any prn analgesic.
Redness, warm to touch day of. Next day redness and swelling had increased in diameter to 14x17 cm's in an oval area.
Janssen COVID-19 Vaccine EUA. When I was going to bed, I had very bad chills, leg cramps, shortness of breath, and a pounding headache. my vision was a little blurry at times too.
Information was received by a physician regarding a teenage female who was vaccinated with GARDASIL intramuscularly (dose was given as "0, 2, and 6 months"); however it is unknown how many doses the patient received. Subsequently, the patient complained of hair loss and fatigue. It was unsure if dosing schedule had been completed. It was reported that the events did not improve/ that the patient had not recovered. No further information is expected.
Appx 12 hours after vaccination with SHINGRIX, patient developed fever (highest was 102 degrees), severe headache, nausea, and chills. These symptoms all resolved about 12 hours after they began.
EXPIRED VACCINE ADMINISTRATION; THE PREFILLED SYRINGE WAS OUT OF THE 2 HOUR FRAME BY 15 MINUTES; This spontaneous report received from a health care professional concerned a 49 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 21-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-MAY-2021, the subject experienced expired vaccine administration. On 21-MAY-2021, the subject experienced the prefilled syringe was out of the 2 hour frame by 15 minutes. The action taken with covid-19 vaccine was not applicable. The outcome of the expired vaccine administration and the prefilled syringe was out of the 2 hour frame by 15 minutes was not reported. This report was non-serious.
Arm and shoulder soreness. Inflammation at injection site. Fever of 100.8 (avg temp for me is 96.8). Extreme chills. Joint aches. Headache ? worse with light.
JanssenCOVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen Vaccine 3/16/2021. Presented to ED on 1/3/2022  with c/o worsening cough  x8 days ago with a +COVID test. Reports associated fever and CP with cough, no alleviating factors. Admitted for acute hypoxic respiratory failure from COVID-19 pneumonia. Course complicated by septic shock, spontaneous retroperitoneal bleed, and NSTEMI. Required multiple pressors and had worsening hypoxia despite max vent support. PEA arrest, expired despite prolonged CPR on 01/15/22.
expired dose administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The patient received second booster dose of moderna COVID-19 vaccine. It was reported that the product was expired 4 days prior. The patient had no further information about the storage or other information about the vaccine. No treatment medication was reported.
04/19/2010 Complaint of muscle pain throughout upper arm and radiated up neck and head.
Patient was given immunization at approx. 10:19am, Pt. gave back 15 minute timer at 10:41am,  at 10:49am per AP (watched video) patient collapsed.  Management arrived at 10:51am to assist.  The report submitted by AP stated that patient had grabbed another customer and a clothes rack then fell to the ground.  Customer stated patient had a seizure. When AP, arrived patient was unconscious and not shaking.  A different customer was there to comfort the patient through the seizure.  Per AP, patient was unconscious for 19 minutes and when she awoke she could not state her name or basic information.  She was helped into a chair.   After 11 minutes she could lucidly state her name and give basic information.  EMTs arrived, assessed her, and transported her to further medical attention. We administered IMZ and are reporting adverse reaction but were not there to witness actual event (only the reports thereafter).
"consumer child recv vax & mom devel shingles w/red, raised, crusted, vesicular lesions below ribs & rt side, although did not recv varicella vax;"
mild fever; Extreme fatigue; This is a spontaneous report received from a contactable consumer (patient). A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration in left arm on 08Apr2021 (Lot Number: EP7533) as single dose for COVID-19 immunization. The patient medical history not reported. Concomitant medication included azithromycin (ZITHROMAX) and hormonal birth control. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), via an unspecified route of administration in left arm on 19Mar2021 (Lot Number: ER8727) as single dose for COVID-19 immunization. The patient received hormonal birth control within 2 weeks of vaccination. On 09Apr2021 19:00, the patient experienced extreme fatigue and mild fever, 30 hours post vaccination of the second dose. The patient did not receive any treatment. The outcome of the events was recovered on an unspecified date in Apr2021.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Mom reported patient Rt. leg muscle tightening with slight foot contracture with toes pulling in. Patient was favoring leg and limping. This was seen by mom after school approximately 1:30 pm on same day as vaccine given. Pt was giving Tylenol and Motrin with good results. Mom reported symptoms gone this morning.
he had a fall due to weakness and wife was not able to get him off the floor.  he was taken to the ER.
came down with shingles within 2 days; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient's friend. The age at vaccination was not reported. The patient got the Shingles shots and came down with shingles within 2 days. The follow-up would not possible as no contact details were available. This case was linked with US2022AMR006103, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR006103:same reporter
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: patient recieved vaccine on Friday 08/20, patients mother called on Tuesday 08/24, stating her son had a rash on torso that started on monday 08/21, no other symptoms present. patients mother gave him diphenhydramine and cortisone cream. relation to covid vaccine cannot be ruled out.
Muscle ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle ache) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included IBUPROFEN for Headache and Myalgia.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced MYALGIA (Muscle ache) and HEADACHE (headache). On 01-Jan-2021, MYALGIA (Muscle ache) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen 400 milligrams.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: NNI
Fever; Nausea; Headache; body aches; Fatigue; This is a spontaneous report from a non-contactable consumer or other non-healthcare professional (the patient). A male patient of an unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number: eW0170, expiry date: not reported), via an unspecified route of administration on 05May2021 as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection, Batch/Lot number: EW0170, expiry date: not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. On 06May2021, the patient experienced fever, nausea, headache, body aches, and fatigue. No treatment was received for all the reported events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.
3rd GARDASIL injected into left deltoid. Pt became dizzy, visual disturbances, severe stomach cramps and R hand cramped up and "felt dead" It took 1 hour for patient's hand to uncramp and have feeling in it.
Redness, pain started 3/28/12. It progressively got worse, seen at ER on 3/31/12. DX (1) vaccination complication (2) cellulitis. Tx: BENADRYL Rx - KEFLEX - MEDROL Dose Pack, VICODIN, IV ROCEPHIN 3/31, 4/1 AND 4/2.
Pt recv vax on 11/9/98; on 11/11/98 pt exp fever (102) x 5 day; aches & pain, stiff neck, sore muscles, sore throat, cough, chills
Leg and hip pain, nerve pain on left side. Shingles mainly on left side but also on right indicating something severely wrong in a young healthy patient.
Maculopapular/vesicular rash of upper extremities and lower extremities; some lesions with erythematous bases and scaling and excoriation (most likely due to scratching). No fever, nausea, vomiting, or lymphadenopathy.  Suspect erythema multiforme minor.
Dizziness; Shortness of breath; Tiredness; This is a spontaneous report from a contactable consumer. This 68-year-old female consumer reported for herself that: This case has been considered invalid as there is no indication that the patient experienced any adverse event under suspect product BNT162B2.  Follow-up (05Mar2021): The initial case was missing the following minimum criteria: since only medical inquiry. Upon receipt of follow-up information on (05Mar2021), this case now contains all required information to be considered valid.  A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EM8810), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 14:00 (at the age of 68-years-old) as dose 1, single for covid-19 immunization. Medical history included mitral valve replacement from Apr2020 to an unknown date, Blood Pressure and Heart, ankel Swelling. Concomitant medications included furosemide (LASIX [FUROSEMIDE]) taken for Ankle swelling; carvedilol taken for blood pressure; spironolactone taken for Ankle swelling; potassium taken for Ankle swelling (joint swelling), all the concomitant medications was ongoing. No history of all previous immunization with the Pfizer vaccine considered as suspect. No adverse events prior vaccinations. No family medical history relevant to adverse events. On 04Mar2021, the patient experienced shortness of breath (yesterday evening around 7pm, as reported) and tiredness (yesterday morning around 8am, as reported), on 05Mar2021 dizziness. (Serious: No, as reported). No emergency room and physician office visit. Outcome of the events shortness of breath and tiredness was recovered on 04Mar2021 and dizziness was recovered on 05Mar2021 (lasted for 30 minutes, as reported).  Additional Context: Calling about the Covid 19 Vaccine. States that she got it the day before yesterday, on 03Mar2021. She is calling in to report her side effects from yesterday. States that she was really tired, and got short of breath; and she also had a dizzy spell this morning. Caller does not have the full contact information to provide for her primary care physician. Dizziness lasted about 30 minutes. Shortness of breath started yesterday evening around 7pm; it went away around 8-9pm last night. The tiredness started around 8am. She felt like she didn't have any energy, so she just laid around all day. It went away around 5pm yesterday evening.  No follow-up attempts are possible. No further information is expected.
(L) deltoid approx 4" x 5" reddened are at injection site. Warm to touch. Occurring approx 2 days after injection. Treated with ice and BENADRYL.
Almost immediately after vaccination, pt felt like her tongue and lips were numb and tingling, also happened with first dose of Pfizer vaccine, but never progressed, eventually went away.  VS 150/88 60 99%RA, EMS evaluated for visible swelling or difficulties breathing, none noted.  Pt remained stable, numbness disappeared and pt released by EMS after 40 minutes, husband drove
Expired vaccine administered due to vaccine temperature excursion. Manufacturer called and advised office to readminister vaccine. Patient revaccinated on 03/19/21
continuous Body aches alternating Chills and Sweatiness  Chills to sweatiness about 2 hours apart   Administered Tylenol 500 mg every 4 hours
Redness, pruritus Improved next day, but still present First two injections were  Moderna; only adverse reaction was pain at vaccination site
Erythema, tenderness at site. Patient states that the soreness involved his entire deltoid. He was treated with Keflex and states that the arm wsa back to normal by 10/8/02.
reddened raised lump on rt upper arm w/sl lighter center-lump is hard (approx 10mm) pt c/o itch area covers inj site of varicella;
Dull, throbbing soreness at injection site.  Began 3 weeks after second dose.  Have experienced this for 2 days off and on.   Different type of soreness to the muscle pain experienced for 2-3 days post injection.
3x2 cm pink tender plaque Right arm 2+ weeks after immunizations? At site of immunization. Put on Valacyclovir 500g 2 tabs TIDx7days and Prednisone. Improved slightly, then came back. Triamcinolone cream, went away x2wks then returned on 1/9/17.
Patient was admitted to Hospital on 7/14 after after two weeks of weakness and found to have AKI and cholestatic liver injury of unknown origin. His clinical course was complicated by progressive liver failure (bili to 20s, LFts >6K), hypoxemic respiratory failure, renal failure requiring dialysis), and a CK >120K.  He had an extensive workup including MRCP,  Pan CT, liver and muscle biopsy which did not reveal definitive dx. Leading diagnosis is statin -induced immune mediated necrotizing myositis, though biopsy not quite consistent and his labs are beyond what has been reported in the literature. He passed away on 7/28 despite treatment with IVIG, pulse dose steroids, broad spectrum abx. Cause of acute decompensation still unknown, autopsy pending. But wife noted he received covid vaccine doses x2 a few weeks prior to hospitalization, which warranted reporting due to unexplained etiology.
Initial report was received via a search of the scientific literature on 03 June 2011. The patient captured in this case was one of eight patients noted in a reference who experienced anaphylaxis after receiving a diphtheria, tetanus and acellular pertussis containing vaccine (manufacturer unknown). These patients tolerated their initial vaccinations but reacted to booster doses. A 16-year-old female patient had received an injection of Tdap vaccine (manufacturer unknown, lot number, route, site and date of administration not reported) and within one hour after vaccination, she developed anaphylaxis with symptoms of nasal congestion, watery eyes, hives, wheezing and chest tightness. Corrective treatments consisted of diphenhydramine and an oral steroid. The patient had a history of milk allergy demonstrated by cough, wheezing and vomiting after milk at one year of age and a subsequent event of respiratory distress, vomiting, hypotension and cardiac arrest after eating pasta sprinkled with cheese at eight years of age. Laboratory testing showed the patient had increased IgE levels (>100) within two years of vaccination. Outcome was not reported. This patient had previously been referenced in case number 2011-01614. The other seven patients have been captured in case numbers 2011-03272, -03275, -03276, -03277, -03278, -03279, and -03281. Documents held by sender: None.
Hives that lasted for 5 days and resolved.; This case was reported by a consumer via call center representative and described the occurrence of hives in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2021, the patient received the 1st dose of Shingrix. In November 2021, immediately after receiving Shingrix, the patient experienced hives. On an unknown date, the outcome of the hives was recovered/resolved.   It was unknown if the reporter considered the hives to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingrix vaccine and experienced hives almost immediately after the dose. The hives lasted for 5 days and resolved. The reporter did not consent to follow-up.
Patient received her second dose of Pfizer vaccine 10/13/21 08:00am and has had a fever(102-103.4-F), chills, myalgias, nausea, for over 24hrs. Fever is not responding to APAP, ASA or Motrin. She tried Zofran with minimal relief. Pt is not registered with system and is reporting adverse side effects to PCP office. Vaccine administered yesterday at pharmacy. Patient advised to go to ER due to lack of response to antipyretics and inability to tolerate oral hydration due to nausea. Should I complete a VAERS report?  Patient declined suggestion to go to ER for evaluation.  She reports the fever broke on Sat 10/16/21 and symptoms improved.  She states she now has a cold.
Pt had shingrix on 04/22/22, admit 04/28/22 with lymphadenopathy in same arm, new bilateral DVTs, seizures, meningitis-like syndome
pt recvd vax & devel arthritic pain; pt taken to MD & was dx w/ rheumatoid arthritis;